Authors: Sikand, VK Halsey, N Krause, PJ Sood, SK Geller, R Van Hoecke, C Buscarino, C Parenti, D

Citation: Vk. Sikand et al., Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein a vaccine against Lyme disease in healthy children and adolescents: A randomized controlled trial, PEDIATRICS, 108(1), 2001, pp. 123-128

Authors: Vaz, A Glickstein, L Field, JA McHugh, G Sikand, VK Damle, N Steere, AC

Citation: A. Vaz et al., Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease, INFEC IMMUN, 69(12), 2001, pp. 7437-7444

Authors: Schoen, RT Sikand, VK Caldwell, MC Van Hoecke, C Gillet, M Buscarino, C Parenti, DL

Citation: Rt. Schoen et al., Safety and immunogenicity profile of a recombinant outer-surface protein ALyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months, CLIN THER, 22(3), 2000, pp. 315-325

Authors: Krause, PJ Lepore, T Sikand, VK Gadbaw, JJ Burke, G Telford, SR Brassard, P Pearl, D Azlanzadeh, J Christianson, D McGrath, D Spielman, A

Citation: Pj. Krause et al., Atovaquone and azithromycin for the treatment of babesiosis., N ENG J MED, 343(20), 2000, pp. 1454-1458

Authors: Sikand, VK Rothel, JS Martin, RM

Citation: Vk. Sikand et al., Diagnosis of Lyme borreliosis by a whole-blood gamma interferon assay for cell-mediated immune responses, CL DIAG LAB, 6(3), 1999, pp. 445-445

Authors: Trevejo, RT Krause, PJ Sikand, VK Schriefer, ME Ryan, R Lepore, T Porter, W Dennis, DT

Citation: Rt. Trevejo et al., Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice, J INFEC DIS, 179(4), 1999, pp. 931-938